Insider Trading & Ownership - Tilton John

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Tilton John
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-06-10
Sale
2020-06-12
5:19 pm
Biohaven Pharmaceutical Holding Co Ltd.BHVNTilton John
Chief Commercial Officer
52,000$67.38$3,504,00138,062
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-10-03
Disposition
2022-10-03
8:27 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd.BHVNTilton John
Chief Commercial Officer
126,407$01,614
(Direct)
View
2022-10-03
Disposition
2022-10-03
8:27 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd.BHVNTilton John
Chief Commercial Officer
6,682$148.51,614
(Direct)
View
2022-01-06
Exercise
2022-01-07
9:18 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd.BHVNTilton John
Chief Commercial Officer
2,125$022,176
(Direct)
View
2022-01-07
Tax Withholding
2022-01-07
9:18 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd.BHVNTilton John
Chief Commercial Officer
342$128.8722,176
(Direct)
View
2022-01-06
Tax Withholding
2022-01-07
9:18 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd.BHVNTilton John
Chief Commercial Officer
551$123.8622,176
(Direct)
View
2022-01-07
Option Award
2022-01-07
9:18 pm
N/A
2032-01-07
Biohaven Pharmaceutical Holding Co Ltd.BHVNTilton John
Chief Commercial Officer
10,500$022,176
(Direct)
View
2021-11-25
Tax Withholding
2021-11-26
4:33 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd.BHVNTilton John
Chief Commercial Officer
492$115.556,281
(Direct)
View
2021-11-25
Exercise
2021-11-26
4:33 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd.BHVNTilton John
Chief Commercial Officer
1,250$06,281
(Direct)
View
2021-01-06
Tax Withholding
2021-01-08
8:49 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd.BHVNTilton John
Chief Commercial Officer
492$83.3823,023
(Direct)
View
2021-01-06
Exercise
2021-01-08
8:49 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd.BHVNTilton John
Chief Commercial Officer
1,250$023,023
(Direct)
View
2021-01-06
Option Award
2021-01-08
8:49 pm
N/A
2031-01-06
Biohaven Pharmaceutical Holding Co Ltd.BHVNTilton John
Chief Commercial Officer
15,000$023,023
(Direct)
View
2020-11-25
Tax Withholding
2020-11-27
9:48 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd.BHVNTilton John
Chief Commercial Officer
480$90.145,654
(Direct)
View
2020-11-25
Exercise
2020-11-27
9:48 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd.BHVNTilton John
Chief Commercial Officer
1,250$05,654
(Direct)
View
2020-06-10
Exercise
2020-06-12
5:19 pm
N/A
2027-01-30
Biohaven Pharmaceutical Holding Co Ltd.BHVNTilton John
Chief Commercial Officer
52,000$038,062
(Direct)
View
2020-06-10
Exercise
2020-06-12
5:19 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd.BHVNTilton John
Chief Commercial Officer
52,000$9.2938,062
(Direct)
View
2019-12-18
Exercise
2019-12-20
9:41 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd.BHVNTilton John
CCO-Rare & Neurologic Disorder
1,250$06,134
(Direct)
View
2019-12-18
Tax Withholding
2019-12-20
9:41 pm
N/A
N/A
Biohaven Pharmaceutical Holding Co Ltd.BHVNTilton John
CCO-Rare & Neurologic Disorder
480$52.136,134
(Direct)
View
2019-11-25
Option Award
2019-11-27
9:31 pm
N/A
2029-11-24
Biohaven Pharmaceutical Holding Co Ltd.BHVNTilton John
CCO-Rare & Neurologic Disorder
15,000$015,000
(Direct)
View